Citation: Ts. Gerstenfeld et Da. Wing, Rectal misoprostol versus intravenous oxytocin for the prevention of postpartum hemorrhage after vaginal delivery, AM J OBST G, 185(4), 2001, pp. 878-882
Authors:
Incerpi, MH
Fassett, MJ
Kjos, SL
Tran, SH
Wing, DA
Citation: Mh. Incerpi et al., Vaginally administered misoprostol for outpatient cervical ripening in pregnancies complicated by diabetes mellitus, AM J OBST G, 185(4), 2001, pp. 916-919
Authors:
Goharkhay, N
Stanczyk, FZ
Gentzschein, E
Wing, DA
Citation: N. Goharkhay et al., Plasma prostaglandin E-2 metabolite levels during labor induction with a sustained-release prostaglandin E-2 vaginal insert, J SOC GYN I, 7(6), 2000, pp. 338-342
Citation: Da. Wing et al., Mifepristone for preinduction cervical ripening beyond 41 weeks' gestation: A randomized controlled trial, OBSTET GYN, 96(4), 2000, pp. 543-548
Citation: Mj. Fassett et al., Longitudinal evaluation of activated protein C resistance among normal pregnancies of Hispanic women, AM J OBST G, 182(6), 2000, pp. 1433-1436
Citation: Da. Wing et al., Limited clinical utility of blood and urine cultures in the treatment of acute pyelonephritis during pregnancy, AM J OBST G, 182(6), 2000, pp. 1437-1441
Citation: Da. Wing et al., A comparison of orally administered misoprostol with vaginally administered misoprostol for cervical ripening and labor induction, AM J OBST G, 180(5), 1999, pp. 1155-1160
Citation: Da. Wing et Rh. Paul, Induction of labor with misoprostol for premature rupture of membranes beyond thirty-six weeks' gestation - Reply, AM J OBST G, 180(1), 1999, pp. 253-254